vs
Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and COMSCORE, INC. (SCOR). Click either name above to swap in a different company.
COMSCORE, INC. is the larger business by last-quarter revenue ($93.5M vs $75.5M, roughly 1.2× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -1.5%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $2.9M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 3.8%).
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
Comscore, Inc. is an American-based global media measurement and analytics company providing marketing data and analytics to enterprises, advertising agencies, brand marketers, and publishers.
PBYI vs SCOR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.5M | $93.5M |
| Net Profit | — | $3.0M |
| Gross Margin | 69.3% | 41.0% |
| Operating Margin | 22.7% | 7.0% |
| Net Margin | — | 3.2% |
| Revenue YoY | 27.7% | -1.5% |
| Net Profit YoY | — | -3.7% |
| EPS (diluted) | $0.26 | $9.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.5M | $93.5M | ||
| Q3 25 | $54.5M | $88.9M | ||
| Q2 25 | $52.4M | $89.4M | ||
| Q1 25 | $46.0M | $85.7M | ||
| Q4 24 | $59.1M | $94.9M | ||
| Q3 24 | $80.5M | $88.5M | ||
| Q2 24 | $47.1M | $85.8M | ||
| Q1 24 | $43.8M | $86.8M |
| Q4 25 | — | $3.0M | ||
| Q3 25 | $8.8M | $453.0K | ||
| Q2 25 | $5.9M | $-9.5M | ||
| Q1 25 | $3.0M | $-4.0M | ||
| Q4 24 | — | $3.1M | ||
| Q3 24 | $20.3M | $-60.6M | ||
| Q2 24 | $-4.5M | $-1.7M | ||
| Q1 24 | $-4.8M | $-1.1M |
| Q4 25 | 69.3% | 41.0% | ||
| Q3 25 | 77.7% | 40.6% | ||
| Q2 25 | 76.5% | 40.6% | ||
| Q1 25 | 77.1% | 39.6% | ||
| Q4 24 | 76.4% | 42.4% | ||
| Q3 24 | 63.9% | 41.2% | ||
| Q2 24 | 77.4% | 39.5% | ||
| Q1 24 | 75.5% | 42.3% |
| Q4 25 | 22.7% | 7.0% | ||
| Q3 25 | 17.6% | 1.9% | ||
| Q2 25 | 12.7% | -1.9% | ||
| Q1 25 | 8.7% | -2.4% | ||
| Q4 24 | 22.6% | 4.1% | ||
| Q3 24 | 27.4% | -67.4% | ||
| Q2 24 | -4.6% | -2.2% | ||
| Q1 24 | -5.3% | -2.2% |
| Q4 25 | — | 3.2% | ||
| Q3 25 | 16.2% | 0.5% | ||
| Q2 25 | 11.2% | -10.6% | ||
| Q1 25 | 6.5% | -4.7% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | 25.2% | -68.5% | ||
| Q2 24 | -9.6% | -2.0% | ||
| Q1 24 | -11.0% | -1.2% |
| Q4 25 | $0.26 | $9.50 | ||
| Q3 25 | $0.17 | $-0.86 | ||
| Q2 25 | $0.12 | $-2.73 | ||
| Q1 25 | $0.06 | $-1.66 | ||
| Q4 24 | $0.40 | $-0.47 | ||
| Q3 24 | $0.41 | $-12.79 | ||
| Q2 24 | $-0.09 | $-1.19 | ||
| Q1 24 | $-0.10 | $-1.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $97.5M | $23.6M |
| Total DebtLower is stronger | $22.7M | $41.5M |
| Stockholders' EquityBook value | $130.3M | $111.4M |
| Total Assets | $216.3M | $407.7M |
| Debt / EquityLower = less leverage | 0.17× | 0.37× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $97.5M | $23.6M | ||
| Q3 25 | $94.4M | $26.7M | ||
| Q2 25 | $96.0M | $26.0M | ||
| Q1 25 | $93.2M | $31.0M | ||
| Q4 24 | $101.0M | $29.9M | ||
| Q3 24 | $96.7M | $20.0M | ||
| Q2 24 | $96.8M | $14.7M | ||
| Q1 24 | $107.2M | $18.7M |
| Q4 25 | $22.7M | $41.5M | ||
| Q3 25 | $34.0M | $41.4M | ||
| Q2 25 | $45.3M | $41.3M | ||
| Q1 25 | $56.7M | $41.3M | ||
| Q4 24 | $68.0M | $41.2M | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
| Q4 25 | $130.3M | $111.4M | ||
| Q3 25 | $115.3M | $-26.3M | ||
| Q2 25 | $104.7M | $-21.7M | ||
| Q1 25 | $97.1M | $-13.5M | ||
| Q4 24 | $92.1M | $-8.3M | ||
| Q3 24 | $71.1M | $-2.7M | ||
| Q2 24 | $48.5M | $45.8M | ||
| Q1 24 | $51.0M | $51.4M |
| Q4 25 | $216.3M | $407.7M | ||
| Q3 25 | $202.9M | $406.9M | ||
| Q2 25 | $194.9M | $415.9M | ||
| Q1 25 | $196.2M | $421.5M | ||
| Q4 24 | $213.3M | $430.2M | ||
| Q3 24 | $220.7M | $412.5M | ||
| Q2 24 | $205.0M | $474.1M | ||
| Q1 24 | $214.1M | $477.7M |
| Q4 25 | 0.17× | 0.37× | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $3.2M |
| Free Cash FlowOCF − Capex | $14.4M | $2.9M |
| FCF MarginFCF / Revenue | 19.1% | 3.1% |
| Capex IntensityCapex / Revenue | 0.0% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 1.07× |
| TTM Free Cash FlowTrailing 4 quarters | $41.7M | $21.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | $3.2M | ||
| Q3 25 | $9.7M | $9.5M | ||
| Q2 25 | $14.1M | $932.0K | ||
| Q1 25 | $3.6M | $9.1M | ||
| Q4 24 | $15.6M | $-10.0M | ||
| Q3 24 | $11.0M | $12.5M | ||
| Q2 24 | $1.0M | $8.7M | ||
| Q1 24 | $11.2M | $6.9M |
| Q4 25 | $14.4M | $2.9M | ||
| Q3 25 | $9.7M | $9.4M | ||
| Q2 25 | $14.1M | $787.0K | ||
| Q1 25 | $3.6M | $8.7M | ||
| Q4 24 | $15.6M | $-10.3M | ||
| Q3 24 | $11.0M | $12.4M | ||
| Q2 24 | $1.0M | $8.5M | ||
| Q1 24 | — | $6.6M |
| Q4 25 | 19.1% | 3.1% | ||
| Q3 25 | 17.7% | 10.5% | ||
| Q2 25 | 26.8% | 0.9% | ||
| Q1 25 | 7.7% | 10.1% | ||
| Q4 24 | 26.4% | -10.8% | ||
| Q3 24 | 13.7% | 14.0% | ||
| Q2 24 | 2.1% | 10.0% | ||
| Q1 24 | — | 7.6% |
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.1% | 0.4% | ||
| Q4 24 | 0.0% | 0.2% | ||
| Q3 24 | 0.0% | 0.1% | ||
| Q2 24 | 0.0% | 0.2% | ||
| Q1 24 | 0.0% | 0.3% |
| Q4 25 | — | 1.07× | ||
| Q3 25 | 1.10× | 20.96× | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | -3.19× | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PBYI
Segment breakdown not available.
SCOR
| Transferred Over Time | $77.1M | 83% |
| Research Insight Solutions | $14.6M | 16% |
| Related Party | $2.5M | 3% |
